ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
247.11
-5.82 (-2.30%)
At close: Mar 10, 2026, 4:00 PM EDT
245.16
-1.95 (-0.79%)
After-hours: Mar 10, 2026, 7:46 PM EDT
ResMed Revenue
ResMed had revenue of $1.42B in the quarter ending December 31, 2025, with 10.98% growth. This brings the company's revenue in the last twelve months to $5.40B, up 9.57% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.
Revenue (ttm)
$5.40B
Revenue Growth
+9.57%
P/S Ratio
6.64
Revenue / Employee
$540,894
Employees
9,980
Market Cap
35.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
| Jun 30, 2019 | 2.61B | 266.38M | 11.38% |
| Jun 30, 2018 | 2.34B | 273.46M | 13.23% |
| Jun 30, 2017 | 2.07B | 228.02M | 12.40% |
| Jun 30, 2016 | 1.84B | 159.80M | 9.52% |
| Jun 30, 2015 | 1.68B | 123.94M | 7.97% |
| Jun 30, 2014 | 1.55B | 40.52M | 2.68% |
| Jun 30, 2013 | 1.51B | 145.94M | 10.66% |
| Jun 30, 2012 | 1.37B | 125.37M | 10.08% |
| Jun 30, 2011 | 1.24B | 150.79M | 13.80% |
| Jun 30, 2010 | 1.09B | 171.62M | 18.64% |
| Jun 30, 2009 | 920.74M | 85.34M | 10.22% |
| Jun 30, 2008 | 835.40M | 119.07M | 16.62% |
| Jun 30, 2007 | 716.33M | 109.34M | 18.01% |
| Jun 30, 2006 | 607.00M | 181.49M | 42.65% |
| Jun 30, 2005 | 425.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medline | 28.43B |
| Becton, Dickinson and Company | 21.92B |
| Baxter International | 11.24B |
| Alcon | 10.40B |
| Intuitive Surgical | 10.06B |
| Solventum | 8.33B |
| The Cooper Companies | 4.15B |
| Hologic | 4.13B |
RMD News
- 7 days ago - Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach - GlobeNewsWire
- 13 days ago - ResMed At $250: Missed Opportunity Or A Trap In The Making? - Forbes
- 14 days ago - Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana - GlobeNewsWire
- 22 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 5 weeks ago - Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge - Reuters
- 5 weeks ago - ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell - Seeking Alpha
- 5 weeks ago - Analysts Maintain Bull Case On ResMed Despite Competition Concerns - Benzinga
- 5 weeks ago - ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript - Seeking Alpha